Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Clinics in Liver Disease|April 29, 2022
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney DiseaseEmily Truong, Mazen NoureddinClinical Liver Disease|July 28, 2022
Improvement in nonalcoholic fatty liver disease through bariatric surgeryEmily Truong, Mazen NoureddinEbiomedicine|April 11, 2022
Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancerEmily Truong, Stephen Pandol, Christie JeonJournal of Clinical Gastroenterology|June 19, 2018
Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis CirrhosisElizabeth Aby, Jennifer Phan, Emily Truong, et al.Mutagenesis|August 4, 2025
"Computational Prediction of Mutagenicity Through Comprehensive Cell Painting Analysis"Natacha Cerisier, Emily Truong, Taku Watanabe, et al.Seminars in Liver Disease|June 16, 2022
Nonalcoholic Steatohepatitis Drug Development Pipeline: An UpdateNicholas W S Chew, Cheng Han Ng, Emily Truong, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2023
MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related DeathEmily Truong, Jeffrey A Gornbein, Ju Dong Yang, et al.Digestive Diseases and Sciences|March 24, 2025
Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLDEmily Truong, Lynna Alnimer, Jeffrey A Gornbein, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 7, 2025
Multiparametric magnetic resonance imaging may improve detection of patients with at-risk MASH: Real world experience in hepatology clinicsMeaghan M Phipps, Tatiana Hage, Emily Truong, et al.Journal of Hepatology|November 19, 2021
MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosisMazen Noureddin, Emily Truong, Jeffrey A Gornbein, et al.Pageof 3